leisure time -WSS

leisure time

author：fashion 2025-09-30 00:09:44 - browse：234

A display of TVs against an orange background. -- health policy coverage from STAT — Adobe

WASHINGTON — Government regulators may soon decide whether to crack down on distracting visuals in television drug commercials or require subtitles about side effects, a regulation that’s been 13 years in the making.

White House budget experts are reviewing changes to the regulation of broadcast drug advertisements that the Food and Drug Administration proposed in 2010, according to the Office of Management and Budget website. That proposal aimed to make commercials present drug risks in a manner that consumers notice and understand.

Drug ads have long been controversial. Aside from New Zealand, the United States is the only country that allows drug makers to advertise to consumers. Critics of drug ads say they pose consumer safety concerns by bombarding the public with promotions that distract viewers from potential side effects. Drug companies say commercials spark conversations between patients and doctors that promote clinically beneficial prescribing.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Tori Bowie and the unacceptable rates of Black maternal death
Next article： Poor hospice wound care hurts patients and families

hotspot

WSS

Slovenia has suffered its worst

PBM reforms clear House panel

Buoyed by wins on obesity, Novo Nordisk eyes heart disease

PBM reforms clear House panel

World's first CRISPR

Doctors push to include dialysis machines in emergency stockpile

Wikipedia

leisure time

hotspot

Peter Hotez and the public health issue of online harassment

Mexico finds 491 migrants being held at vacant lot, almost all are from Guatemala

Medical leaders decry Supreme Court decision on affirmative action

Doctors are clamoring for more clarity on Paxlovid prescribing

Affirmative action in medical school literally saved lives

Judge in Trump's classified documents case questions use of out

Psychedelics group wrestles with new pharma identity

Feed a cold, starve a fever? Here’s what science says

Alkermes shareholders re

PBM reforms clear House panel

leisure time

Readout Newsletter: Bayer study halts, Carmot to IPO, and more

Trump used to be more articulate. What could explain the change?

Readout LOUD podcast: A CRISPR milestone, biotech mixology

World's first CRISPR

Election results set back Medicaid expansion plans

Weight loss drug Wegovy cuts risk of heart attacks in milestone trial

leisure time

hotspot

hotspot

Wikipedia